BIA
Bigelow Investment Advisors Portfolio holdings
AUM
$227M
This Quarter Return
+2.95%
1 Year Return
+13.46%
3 Year Return
+50.43%
5 Year Return
+71.23%
10 Year Return
–
AUM
$149M
AUM Growth
+$149M
(+3.4%)
Cap. Flow
+$1.54M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
33.22%
Holding
155
New
5
Increased
59
Reduced
68
Closed
5
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$1.79M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$418K |
| 3 |
General Motors
GM
|
$270K |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
$270K |
| 5 |
iShares GNMA Bond ETF
GNMA
|
$255K |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$349K |
| 2 |
CELG
Celgene Corp
CELG
|
$307K |
| 3 |
IBM
IBM
|
$238K |
| 4 |
Novartis
NVS
|
$233K |
| 5 |
DuPont de Nemours
DD
|
$228K |
Sector Composition
| 1 | Technology | 9.88% |
| 2 | Healthcare | 7.11% |
| 3 | Industrials | 5.55% |
| 4 | Communication Services | 4.79% |
| 5 | Financials | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
DuPont de Nemours
DD
$31.7B
| – | – |
-4,284
| Closed | -$228K |
|
152
GSK
GSK
$78.5B
| – | – |
-5,100
| Closed | -$213K |
|
|
153
Novartis
NVS
$245B
| – | – |
-2,424
| Closed | -$233K |
|
154
SPDR S&P Biotech ETF
XBI
$5.25B
| – | – |
-2,270
| Closed | -$206K |
|
|
CELG
155
DELISTED
Celgene Corp
CELG
| – | – |
-3,249
| Closed | -$307K |
|